Stock Market News

Ocugen (OCGN) Completes Enrollment for Phase 2/3 Pivotal Trial of OCU410ST Gene Therapy

wccwcc
May 2, 2026 - 11:00
 0  1
Ocugen (OCGN) Completes Enrollment for Phase 2/3 Pivotal Trial of OCU410ST Gene Therapy

What's Your Reaction?

like like 0
dislike dislike 0
love love 0
funny funny 0
angry angry 0
sad sad 0
wow wow 0
wcc
wcc

Related Posts

Postal Service proposes requiring states to provide mail-in ballot voter lists

Postal Service proposes requiring states to provide mai...

wcc May 30, 2026  0  1

Jim Cramer says Dell’s blowout quarter sets up a crucial week for AI stocks

Jim Cramer says Dell’s blowout quarter sets up a crucia...

wcc May 30, 2026  0  0

Brent oil price posts biggest monthly loss in six years as market counts on a U.S.-Iran deal

Brent oil price posts biggest monthly loss in six years...

wcc May 30, 2026  0  1

Blue Origin warns of rocket explosion debris after failed New Glenn test at Cape Canaveral

Blue Origin warns of rocket explosion debris after fail...

wcc May 30, 2026  0  1

U.S. support for Taiwan reaffirmed by members of Congress even after Trump called arms sales a 'negotiating chip' with China

U.S. support for Taiwan reaffirmed by members of Congre...

wcc May 30, 2026  0  0

IRS unveils new health savings account limits for 2027

IRS unveils new health savings account limits for 2027

wcc May 30, 2026  0  0